Avara celebrates anniversary of Arecibo acquisition

Avara Pharmaceutical Services Inc. recently celebrated the one-year anniversary of its purchase of the Arecibo site in Puerto Rico from Merck.

In the year since the acquisition, Avara has accrued four manufacturing facilities in four different countries that now have approximately 800 employees.

"As we celebrate these key milestones, we continue with great confidence to build a pharmaceutical services company with complementary offerings in key regions in this rapidly growing market,” Avara Chairman and CEO Tim Tyson said. “Each site has significant professional experience, state of the art capabilities and a long history of delivering high quality pharmaceuticals that meet or exceed customer expectations and regulatory requirements in every major market around the world. The people that are a part of the Avara team are the key to our long term success."

The most recent purchase for Avara came when it bought an AstraZeneca manufacturing facility in Avlon, Avonmouth, England. Avara purchased the site in Avlon due to the formulation and manufacturing capabilities for active pharmaceutical ingredient (API), which goes hand-in-hand with its API operation located in Shannon, Ireland.